Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 49, 2014 - Issue 10
Submit an article Journal homepage
619
Views
8
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort

Philippe HirozDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;Division of Gastroenterology and Hepatology, Stadtspital Triemli, Zurich, Switzerland
,
Stephan R. VavrickaDivision of Gastroenterology and Hepatology, Stadtspital Triemli, Zurich, Switzerland;Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
,
Nicolas FournierInstitute of Social and Preventive Medicine, Université de Lausanne, Lausanne, Switzerland
,
Ekaterina SafroneevaInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
,
Valérie PittetInstitute of Social and Preventive Medicine, Université de Lausanne, Lausanne, Switzerland
,
Gerhard RoglerDivision of Gastroenterology and Hepatology, Stadtspital Triemli, Zurich, Switzerland
,
Alain M. SchoepferDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, Lausanne, SwitzerlandCorrespondence[email protected]
& on behalf of the Swiss Inflammatory Bowel Diseases Cohort Study Group* show all
Pages 1207-1218 | Received 04 May 2014, Accepted 03 Jul 2014, Published online: 14 Aug 2014

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Harpreet Singh, Liam Wilson, Tom Tencer & Jinender Kumar. (2023) Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis. ClinicoEconomics and Outcomes Research 15, pages 125-138.
Read now
Ian C Lawrance. (2015) Early investigational TNF receptor antagonists for the treatment of ulcerative colitis. Expert Opinion on Investigational Drugs 24:6, pages 761-768.
Read now

Articles from other publishers (6)

Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker, Mark C. H. de Groot, Kris L. L. Movig, Johan Kuijvenhoven, Toine C. G. Egberts, Hubert G. M. Leufkens & Thijs J. Giezen. (2021) Switching TNFα inhibitors: Patterns and determinants. Pharmacology Research & Perspectives 9:4.
Crossref
Laurent Peyrin-Biroulet, William J. Sandborn, Remo Panaccione, Eugeni Domènech, Lieven Pouillon, Britta Siegmund, Silvio Danese & Subrata Ghosh. (2021) Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues. Therapeutic Advances in Gastroenterology 14, pages 175628482110599.
Crossref
V.I. Ignatieva, M.V. Avksentieva, V.V. Omelyanovsky & E.V. Derkach. (2020) Socioeconomic burden of inflammatory bowel disease in the Russian Federation. Profilakticheskaya meditsina 23:2, pages 19.
Crossref
Alain Schoepfer, Stephan R. Vavricka, Beat Brüngger, Oliver Reich, Eva Blozik & Caroline Bähler. (2018) Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland. European Journal of Gastroenterology & Hepatology 30:8, pages 868-875.
Crossref
Helena Shifrin, Dorit Moradov, Corina Bejar, Donna Schorer-Apelbaum & Marta Weinstock. (2016) Novel indoline derivatives prevent inflammation and ulceration in dinitro-benzene sulfonic acid-induced colitis in rats. Pharmacological Reports 68:6, pages 1312-1318.
Crossref
J. P. Gisbert, A. C. Marín, A. G. McNicholl & M. Chaparro. (2015) Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed. Alimentary Pharmacology & Therapeutics 41:7, pages 613-623.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.